7-81974525-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_000722.4(CACNA2D1):c.1983G>A(p.Ser661=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00232 in 1,564,042 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0024 ( 4 hom. )
Consequence
CACNA2D1
NM_000722.4 synonymous
NM_000722.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 7-81974525-C-T is Benign according to our data. Variant chr7-81974525-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 238180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-81974525-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.23 with no splicing effect.
BS2
High AC in GnomAd4 at 289 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA2D1 | NM_000722.4 | c.1983G>A | p.Ser661= | synonymous_variant | 25/39 | ENST00000356860.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.1983G>A | p.Ser661= | synonymous_variant | 25/39 | 1 | NM_000722.4 | ||
CACNA2D1 | ENST00000443883.2 | c.2019G>A | p.Ser673= | synonymous_variant | 25/39 | 5 | P1 | ||
CACNA2D1 | ENST00000705962.1 | c.1863G>A | p.Ser621= | synonymous_variant | 24/38 | ||||
CACNA2D1 | ENST00000705961.1 | c.1752G>A | p.Ser584= | synonymous_variant | 23/37 |
Frequencies
GnomAD3 genomes AF: 0.00191 AC: 289AN: 150964Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
289
AN:
150964
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00164 AC: 399AN: 243696Hom.: 0 AF XY: 0.00160 AC XY: 211AN XY: 131788
GnomAD3 exomes
AF:
AC:
399
AN:
243696
Hom.:
AF XY:
AC XY:
211
AN XY:
131788
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00236 AC: 3339AN: 1412968Hom.: 4 Cov.: 25 AF XY: 0.00235 AC XY: 1657AN XY: 705402
GnomAD4 exome
AF:
AC:
3339
AN:
1412968
Hom.:
Cov.:
25
AF XY:
AC XY:
1657
AN XY:
705402
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00191 AC: 289AN: 151074Hom.: 3 Cov.: 32 AF XY: 0.00160 AC XY: 118AN XY: 73716
GnomAD4 genome
AF:
AC:
289
AN:
151074
Hom.:
Cov.:
32
AF XY:
AC XY:
118
AN XY:
73716
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | CACNA2D1: BP4, BP7, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 05, 2017 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Brugada syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 09, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at